Marc Besselink (1976) is a Hepato-Pancreato-Biliary (HPB) surgeon at the Amsterdam University Medical Centers, location AMC, the Netherlands with a strong clinical and research interest in pancreatic cancer, pancreatitis and laparoscopic HPB surgery. Marc finished his medical training in Utrecht in 2002. He earned his PhD (cum laude) on acute pancreatitis from Utrecht University in 2008 and MSc in Evidence-Based Health Care from Oxford University in 2014.

In 2002, he was the co-founder of the Dutch Pancreatitis Study Group (www.pancreatitis.nl) and in 2012 he was the co-founder of the Dutch Pancreatic Cancer Group (www.dpcg.nl). He has coordinated the 2013 Evidence-Based Guidelines for the Management of Acute Pancreatitis for the International Association of Pancreatology and the American Pancreatic Association. He has published over 240 peer-reviewed papers and has (co-)developed and (co-)coordinated multiple randomized controlled multicenter trials in acute pancreatitis and pancreatic cancer, several of which are published in The Lancet, New England Journal of Medicine and JAMA. In 2018, Marc Besselink became full professor in Hepato-Pancreato-Biliary Surgery at the University of Amsterdam.